🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/02/2016 3,27 3,40 3,11 3,18 -1,85% 8,87% 814.100
08/02/2016 3,40 3,42 3,14 3,24 -6,36% 8,12% 769.200
05/02/2016 3,73 3,73 3,46 3,46 -6,23% 7,24% 792.600
04/02/2016 3,40 3,86 3,35 3,69 +8,53% 14,97% 928.300
03/02/2016 3,26 3,40 3,12 3,40 +4,62% 8,59% 1.047.300
02/02/2016 3,41 3,44 3,20 3,25 -5,80% 7,04% 819.400
01/02/2016 3,45 3,50 3,32 3,45 -0,86% 5,22% 546.600
29/01/2016 3,48 3,60 3,36 3,48 +0,00% 7,04% 843.800
28/01/2016 3,69 3,69 3,40 3,48 -4,40% 7,86% 791.100
27/01/2016 3,72 3,79 3,58 3,64 -2,54% 5,65% 616.300
26/01/2016 3,84 3,84 3,55 3,74 -2,73% 7,55% 964.200
25/01/2016 4,16 4,25 3,83 3,84 -8,35% 10,10% 937.900
22/01/2016 4,08 4,30 3,96 4,19 +4,75% 8,33% 777.000
21/01/2016 4,06 4,09 3,75 4,00 +0,50% 8,37% 893.400
20/01/2016 3,70 4,10 3,26 3,98 +3,65% 22,70% 1.886.500
19/01/2016 4,70 4,75 3,84 3,84 -16,16% 19,36% 2.461.700
15/01/2016 4,63 4,75 4,41 4,58 -4,38% 7,34% 1.196.600
14/01/2016 4,64 4,91 4,41 4,79 +3,01% 10,78% 948.000
13/01/2016 4,95 5,12 4,61 4,65 -6,63% 10,30% 1.000.100
12/01/2016 5,04 5,28 4,80 4,98 -1,19% 9,52% 1.358.400
11/01/2016 5,36 5,49 4,86 5,04 -5,97% 11,75% 1.260.600
08/01/2016 5,38 5,66 5,26 5,36 +1,13% 7,43% 1.052.200
07/01/2016 5,18 5,41 5,01 5,30 -2,75% 7,82% 2.218.200
06/01/2016 5,74 5,84 5,34 5,45 -7,16% 8,66% 1.284.100
05/01/2016 5,94 6,04 5,76 5,87 -1,84% 4,80% 724.800
04/01/2016 5,97 6,05 5,85 5,98 -2,76% 3,35% 985.800
31/12/2015 6,10 6,24 6,05 6,15 +0,33% 3,03% 550.300
30/12/2015 6,18 6,25 6,08 6,13 -1,13% 2,75% 725.600
29/12/2015 6,22 6,29 6,15 6,20 +0,16% 2,25% 560.600
28/12/2015 6,18 6,30 6,05 6,19 -0,16% 4,05% 603.200